BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33053970)

  • 1. [Role of hepatic venous pressure gradient in the overall management process of portal hypertension].
    Wang HL; Sun JH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):728-731. PubMed ID: 33053970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation and treatment of portal hypertension].
    Brůha R; Petrtýl J
    Cas Lek Cesk; 2016; 155(2):22-6. PubMed ID: 27088788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis.
    Le Moine O; Hadengue A; Moreau R; Sogni P; Soupison T; Yang S; Hartleb M; Lebrec D
    Scand J Gastroenterol; 1997 Jul; 32(7):731-5. PubMed ID: 9246716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage.
    Vorobioff JD; Groszmann RJ
    Ann Hepatol; 2013; 12(1):22-9. PubMed ID: 23293190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and treatment of esophageal varices in the cirrhotic patient.
    Ashkenazi E; Kovalev Y; Zuckerman E
    Isr Med Assoc J; 2013 Feb; 15(2):109-15. PubMed ID: 23516775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing liver cirrhotic complications: Overview of esophageal and gastric varices.
    Lesmana CRA; Raharjo M; Gani RA
    Clin Mol Hepatol; 2020 Oct; 26(4):444-460. PubMed ID: 33053928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Portal pressure should be measured on suspicion of portal hypertension].
    Møller S; Bendtsen F
    Ugeskr Laeger; 2010 Dec; 172(49):3411-3. PubMed ID: 21129318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status and prospects of integrated traditional Chinese and Western medicine for treatment of portal hypertension].
    Wang J; Zhu XN; Zhang YR; Gao YQ; Yang YP
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):249-253. PubMed ID: 29996333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond.
    Karagiannakis DS; Voulgaris T; Siakavellas SI; Papatheodoridis GV; Vlachogiannakos J
    Scand J Gastroenterol; 2018; 53(10-11):1153-1164. PubMed ID: 30345856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
    Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive imaging assessment of portal hypertension.
    Kennedy P; Bane O; Hectors SJ; Fischman A; Schiano T; Lewis S; Taouli B
    Abdom Radiol (NY); 2020 Nov; 45(11):3473-3495. PubMed ID: 32926209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.
    Lebrec D; De Fleury P; Rueff B; Nahum H; Benhamou JP
    Gastroenterology; 1980 Dec; 79(6):1139-44. PubMed ID: 6969201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.